NovoCure's Research & Development rose 413.82% to $54.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $214.8 million, marking a year-over-year increase of 98.99%. This contributed to the annual value of $209.6 million for FY2024, which is 601.49% down from last year.
Latest data reveals that NovoCure reported Research & Development of $54.0 million as of Q3 2025, which was up 413.82% from $55.8 million recorded in Q2 2025.
NovoCure's Research & Development's 5-year high stood at $59.7 million during Q1 2023, with a 5-year trough of $42.2 million in Q1 2022.
In the last 5 years, NovoCure's Research & Development had a median value of $53.8 million in 2025 and averaged $52.8 million.
Per our database at Business Quant, NovoCure's Research & Development skyrocketed by 8169.44% in 2021 and then tumbled by 1357.7% in 2024.
Over the past 5 years, NovoCure's Research & Development (Quarter) stood at $56.9 million in 2021, then decreased by 3.71% to $54.8 million in 2022, then decreased by 0.93% to $54.3 million in 2023, then dropped by 5.7% to $51.2 million in 2024, then grew by 5.5% to $54.0 million in 2025.
Its Research & Development was $54.0 million in Q3 2025, compared to $55.8 million in Q2 2025 and $53.8 million in Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value